Disregulation of p16MTS1/CDK4I protein and mRNA expression is associated with gene alterations in squamous-cell carcinoma of the larynx

This publication has 19 references indexed in Scilit:

• Molecular support for field cancerization in the head and neck
  Cancer, 1998
• Mechanisms of p16INK4A inactivation in non small-cell lung cancers
  Oncogene, 1998
• p21WAF1/Cip1 expression is associated with cell differentiation but not with p53 mutations in squamous cell carcinomas of the larynx
  The Journal of Pathology, 1997
• p16MTS1/CDK4I mutations and concomitant loss of heterozygosity at 9p21-23 are frequent events in squamous cell carcinoma of the larynx
  Oncogene, 1997
• Inactivation of P16Ink4 in Hepatocellular Carcinoma
  Hepatology, 1996
• Status and expression of thep16INK4 gene in human thyroid tumors and thyroid-tumor cell lines
  International Journal of Cancer, 1996
• Regulation of p16^CDKN2 Expression and Its Implications for Cell Immortalization and Senescence
  Molecular and Cellular Biology, 1996
• 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers
  Nature Medicine, 1995
• Homozygous Deletions and Loss of Expression of the CDKN2 gene occur frequently in head and neck squamous cell carcinoma cell lines but infrequently in primary tumors
  Genes, Chromosomes and Cancer, 1995
• A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor Types
  Science, 1994